Immuneering Corp Stock Price History
IMRX Stock | USD 2.24 0.15 7.18% |
If you're considering investing in Immuneering Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immuneering Corp stands at 2.24, as last reported on the 20th of October, with the highest price reaching 2.25 and the lowest price hitting 2.05 during the day. Immuneering Corp is very risky given 3 months investment horizon. Immuneering Corp holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.44% are justified by taking the suggested risk. Use Immuneering Corp Market Risk Adjusted Performance of 1.71, downside deviation of 6.52, and Risk Adjusted Performance of 0.1227 to evaluate company specific risk that cannot be diversified away.
At this time, Immuneering Corp's Common Stock Shares Outstanding is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 266.5 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 72 M in 2024. . At this time, Immuneering Corp's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 2.42 in 2024, whereas Price To Sales Ratio is likely to drop 207.26 in 2024. Immuneering Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immuneering |
Sharpe Ratio = 0.1376
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | IMRX | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
10.44 actual daily | 92 92% of assets are less volatile |
Expected Return
1.44 actual daily | 28 72% of assets have higher returns |
Risk-Adjusted Return
0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Immuneering Corp is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immuneering Corp by adding it to a well-diversified portfolio.
Price Book 1.0018 | Enterprise Value Ebitda (1.53) | Price Sales 563.6155 | Shares Float 19.1 M | Wall Street Target Price 11.21 |
Immuneering Corp Stock Price History Chart
There are several ways to analyze Immuneering Stock price data. The simplest method is using a basic Immuneering candlestick price chart, which shows Immuneering Corp price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 20, 2024 | 3.21 |
Lowest Price | August 16, 2024 | 1.03 |
Immuneering Corp October 20, 2024 Stock Price Synopsis
Various analyses of Immuneering Corp's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Immuneering Stock. It can be used to describe the percentage change in the price of Immuneering Corp from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Immuneering Stock.Immuneering Corp Price Daily Balance Of Power | 0.75 | |
Immuneering Corp Price Rate Of Daily Change | 1.07 | |
Immuneering Corp Price Action Indicator | 0.17 |
Immuneering Corp October 20, 2024 Stock Price Analysis
Immuneering Stock Price History Data
The price series of Immuneering Corp for the period between Mon, Jul 22, 2024 and Sun, Oct 20, 2024 has a statistical range of 2.18 with a coefficient of variation of 39.81. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.68. The median price for the last 90 days is 1.24.Open | High | Low | Close | Volume | ||
10/20/2024 | 2.06 | 2.25 | 2.05 | 2.24 | ||
10/18/2024 | 2.06 | 2.25 | 2.05 | 2.24 | 916,632 | |
10/17/2024 | 2.12 | 2.17 | 2.08 | 2.09 | 852,690 | |
10/16/2024 | 2.31 | 2.34 | 2.10 | 2.22 | 1,836,435 | |
10/15/2024 | 2.45 | 2.51 | 2.15 | 2.31 | 25,766,639 | |
10/14/2024 | 2.17 | 2.20 | 1.90 | 2.00 | 942,663 | |
10/11/2024 | 2.22 | 2.26 | 2.12 | 2.19 | 424,518 | |
10/10/2024 | 2.16 | 2.24 | 2.10 | 2.22 | 356,704 | |
10/09/2024 | 2.38 | 2.39 | 2.11 | 2.19 | 821,081 | |
10/08/2024 | 2.47 | 2.55 | 2.30 | 2.39 | 700,822 | |
10/07/2024 | 2.50 | 2.60 | 2.37 | 2.45 | 548,884 | |
10/04/2024 | 2.37 | 2.70 | 2.37 | 2.47 | 1,143,305 | |
10/03/2024 | 2.36 | 2.48 | 2.32 | 2.37 | 420,149 | |
10/02/2024 | 2.26 | 2.49 | 2.20 | 2.43 | 783,699 | |
10/01/2024 | 2.51 | 2.52 | 2.20 | 2.32 | 1,390,475 | |
09/30/2024 | 2.61 | 2.70 | 2.44 | 2.49 | 1,182,585 | |
09/27/2024 | 2.61 | 2.81 | 2.45 | 2.66 | 1,553,813 | |
09/26/2024 | 2.96 | 3.07 | 2.61 | 2.61 | 2,954,296 | |
09/25/2024 | 3.01 | 3.31 | 2.79 | 2.94 | 4,252,033 | |
09/24/2024 | 2.87 | 3.20 | 2.66 | 2.92 | 2,459,602 | |
09/23/2024 | 3.15 | 3.35 | 2.85 | 2.87 | 4,482,488 | |
09/20/2024 | 2.36 | 3.51 | 2.36 | 3.21 | 25,089,801 | |
09/19/2024 | 2.43 | 2.64 | 2.28 | 2.42 | 4,112,157 | |
09/18/2024 | 2.64 | 2.68 | 2.28 | 2.28 | 4,523,065 | |
09/17/2024 | 2.74 | 3.35 | 2.63 | 2.78 | 36,281,107 | |
09/16/2024 | 2.03 | 3.83 | 1.82 | 2.87 | 65,723,021 | |
09/13/2024 | 2.09 | 2.58 | 1.84 | 2.02 | 136,593,014 | |
09/12/2024 | 1.33 | 1.49 | 1.30 | 1.43 | 11,709,942 | |
09/11/2024 | 1.18 | 1.29 | 1.18 | 1.29 | 440,675 | |
09/10/2024 | 1.16 | 1.22 | 1.14 | 1.20 | 297,666 | |
09/09/2024 | 1.17 | 1.19 | 1.12 | 1.16 | 418,420 | |
09/06/2024 | 1.18 | 1.22 | 1.15 | 1.18 | 378,604 | |
09/05/2024 | 1.26 | 1.29 | 1.15 | 1.19 | 686,793 | |
09/04/2024 | 1.17 | 1.33 | 1.16 | 1.25 | 908,388 | |
09/03/2024 | 1.18 | 1.27 | 1.18 | 1.21 | 1,643,124 | |
08/30/2024 | 1.15 | 1.16 | 1.11 | 1.11 | 264,507 | |
08/29/2024 | 1.12 | 1.18 | 1.12 | 1.16 | 171,824 | |
08/28/2024 | 1.11 | 1.17 | 1.10 | 1.13 | 251,179 | |
08/27/2024 | 1.17 | 1.17 | 1.10 | 1.13 | 325,811 | |
08/26/2024 | 1.07 | 1.17 | 1.06 | 1.17 | 454,369 | |
08/23/2024 | 1.06 | 1.08 | 1.01 | 1.07 | 164,623 | |
08/22/2024 | 1.13 | 1.13 | 1.04 | 1.05 | 225,205 | |
08/21/2024 | 1.06 | 1.13 | 1.05 | 1.12 | 254,919 | |
08/20/2024 | 1.07 | 1.08 | 1.01 | 1.07 | 429,572 | |
08/19/2024 | 1.06 | 1.14 | 1.01 | 1.08 | 1,074,376 | |
08/16/2024 | 1.07 | 1.08 | 1.00 | 1.03 | 628,772 | |
08/15/2024 | 1.07 | 1.11 | 1.06 | 1.08 | 494,591 | |
08/14/2024 | 1.10 | 1.15 | 1.07 | 1.08 | 453,479 | |
08/13/2024 | 1.12 | 1.19 | 1.12 | 1.14 | 378,804 | |
08/12/2024 | 1.08 | 1.16 | 1.07 | 1.14 | 501,437 | |
08/09/2024 | 1.09 | 1.14 | 1.07 | 1.09 | 580,419 | |
08/08/2024 | 1.13 | 1.19 | 1.09 | 1.12 | 509,408 | |
08/07/2024 | 1.19 | 1.31 | 1.10 | 1.14 | 848,092 | |
08/06/2024 | 1.26 | 1.37 | 1.19 | 1.24 | 2,303,479 | |
08/05/2024 | 1.12 | 1.35 | 1.10 | 1.22 | 1,227,547 | |
08/02/2024 | 1.32 | 1.46 | 1.18 | 1.33 | 2,843,293 | |
08/01/2024 | 1.55 | 1.77 | 1.29 | 1.35 | 67,188,149 | |
07/31/2024 | 1.15 | 1.18 | 1.13 | 1.13 | 6,827,507 | |
07/30/2024 | 1.27 | 1.29 | 1.11 | 1.13 | 131,470 | |
07/29/2024 | 1.26 | 1.33 | 1.25 | 1.28 | 192,234 | |
07/26/2024 | 1.24 | 1.30 | 1.20 | 1.24 | 65,135 |
About Immuneering Corp Stock history
Immuneering Corp investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immuneering is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immuneering Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immuneering Corp stock prices may prove useful in developing a viable investing in Immuneering Corp
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 28.4 M | 29.1 M | |
Net Loss | -45.5 M | -43.2 M |
Immuneering Corp Quarterly Net Working Capital |
|
Immuneering Corp Stock Technical Analysis
Immuneering Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
All Next | Launch Module |
Immuneering Corp Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immuneering Corp's price direction in advance. Along with the technical and fundamental analysis of Immuneering Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immuneering to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1227 | |||
Jensen Alpha | 1.41 | |||
Total Risk Alpha | 0.3344 | |||
Sortino Ratio | 0.2149 | |||
Treynor Ratio | 1.7 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.